Diabetes Technology Society

What Diabetes Technology Society does

Diabetes Technology Society (DTS) is a nonprofit educational organization founded in 2001 and headquartered in Burlingame, California. It is led by founder and President Dr. David C. Klonoff, an endocrinologist and Clinical Professor of Medicine at UCSF who is credited with coining the term 'diabetes technology.' DTS promotes the development and use of technology to help people with diabetes through a portfolio of programs spanning scientific publishing, conferences, standards development, and independent device surveillance.

DTS's core outputs include the Journal of Diabetes Science and Technology (the world's largest scientific journal devoted to diabetes technology), multiple annual conferences (the Diabetes Technology Meeting, International Hospital Diabetes Meeting, Clinical Diabetes Technology Meeting, and Digital Diabetes Congress), and consensus cybersecurity standards for connected diabetes devices (DTSec and DTMoSt). It also operates the Blood Glucose Monitor System Surveillance Program, which independently tests cleared BGMs against accepted accuracy standards and awards a Seal of Approval; develops clinical assessment tools including the Surveillance Error Grid software and the Glycemia Risk Index (GRI); and runs the iCoDE project for EHR integration standards of insulin delivery data. DTSec certification is delivered through an approved lab network comprising Booz Allen Hamilton, Brightsight, TUV Rheinland, and Underwriters Laboratories.

DTS generates revenue through conference and meeting registrations, corporate sponsorships and exhibits from medical device and pharmaceutical companies (including Abbott Diabetes Care, Ascensia, Roche, Medtronic, and Dexcom), subscription-based journal publishing, and DTSec certification testing fees. It serves a horizontal base of healthcare professionals, diabetes researchers, medical device and pharmaceutical companies, startup companies in the diabetes technology space, and people living with diabetes, operating through direct-to-consumer digital channels, in-person events, and virtual/hybrid formats.

Name

Diabetes Technology Society

Legal name

Diabetes Technology Society

Website

https://diabetestechnology.org

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

Diabetes Technology Society is a nonprofit organization that develops consensus standards (DTSec, DTMoSt), runs post-market surveillance for blood glucose monitors, publishes the Journal of Diabetes Science and Technology, and hosts annual conferences for clinicians, researchers, and medical device companies in the diabetes technology field.

Ownership category

akta.pro rank

Product category

Medical Device Cybersecurity Standards and Diabetes Technology Education

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Continuous Glucose Monitoring (CGM) Systems (HLAHAHAA)

akta.pro secondary industries

Condition-specific Digital Therapeutics (DTx) (HLACANAA), Type 1 Diabetes Care (HLAKADAB)

Keywords

• Diabetes technology standards
• Medical device cybersecurity
• Blood glucose surveillance
• Diabetes research publishing
• Clinical diabetes education

Headquarters

HQ city

Burlingame

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Conference and Meeting Registrations: Revenue generated from registration fees for multiple annual meetings including the Diabetes Technology Meeting (DTM), International Hospital Diabetes Meeting (HDM), Clinical Diabetes Technology Meeting (CDTM), Digital Diabetes Congress (DDC), and various specialty meetings. Registration fees vary by event with Startup Showcase participation at $500.
2. Sponsorships and Exhibits: Corporate sponsorships and exhibit fees from pharmaceutical and medical device companies participating in DTS meetings and events.
3. Journal Publishing: DTS publishes the Journal of Diabetes Science and Technology, the world's largest scientific journal devoted to diabetes technology.
4. Certifications and Testing Services: DTSec certification program for cybersecurity evaluation of connected diabetes devices through approved testing laboratories.

Pricing tiers

Distribution channels4 records

Marketing channels7 records

Core offering

Diabetes Technology Society (DTS) is a nonprofit educational organization that develops consensus cybersecurity standards (DTSec, DTMoSt) for connected diabetes devices, operates an independent Blood Glucose Monitor System Surveillance Program, and publishes the Journal of Diabetes Science and Technology. The organization also produces multiple annual conferences, clinical assessment tools such as the Surveillance Error Grid software and Glycemia Risk Index, and EHR integration standards (iCoDE).

Product overview

Diabetes Technology Society (DTS) is a non-profit educational organization that promotes the development and use of technology to help people with diabetes. Rather than a single unified product, DTS offers a portfolio of programs and services including scientific publishing (Journal of Diabetes Science and Technology), annual conferences (Diabetes Technology Meeting, Clinical Diabetes Technology Meeting, Virtual Hospital Diabetes Meeting), cybersecurity standards development (DTSec, DTMoSt), blood glucose monitoring system surveillance programs with Seal of Approval certification, clinical assessment tools (Surveillance Error Grid Software, Glycemia Risk Index), mobile applications for meeting management, and community outreach initiatives including Salud Diabetes and the Green Diabetes Initiative. DTS also develops interoperability standards through the iCoDE project for EHR integration of insulin delivery data.

Differentiator

Problem solved

Functional benefit

Brands

• Journal of Diabetes Science and Technology: Official journal of DTS, world's largest scientific journal focused on diabetes technology including glucose monitoring, insulin delivery, artificial pancreas, software, wireless health solutions, social media, and bioengineered solutions for treating obesity.
• DTSec
• DTMoSt
• Salud Diabetes

Products and services

• Journal of Diabetes Science and Technology The world's largest scientific journal devoted to diabetes technology, covering glucose monitoring, insulin delivery, artificial pancreas systems, software, wireless health solutions, and bioengineered solutions. It serves researchers, clinicians, and industry subscribers seeking peer-reviewed scientific content focused exclusively on diabetes technology.
• Diabetes Technology Meeting (DTM) Annual conference focused on diabetes technology research, featuring presentations, abstract submissions, a startup showcase, and networking for the diabetes technology community. The flagship in-person meeting is held annually in the U.S. and attracts hundreds to thousands of attendees.
• Virtual Hospital Diabetes Meeting
• Clinical Diabetes Technology Meeting (CDTM) Educational meeting providing hands-on experience with the latest diabetes devices for glucose monitoring and insulin delivery, with CME accreditation for clinicians. ACCME-accredited through joint providership with PESI, Inc., offering up to 8.25 AMA PRA Category 1 Credits and qualifying for CDE continuing education hours.
• Digital Diabetes Congress (DDC) Conference focused on digital health in diabetes care, co-presented with Sansum Diabetes Research Institute. Dr. David Kerr from Sansum serves as Director of Research and Innovation for the DDC.
• DTSec Cybersecurity Standard The first consensus cybersecurity standard for connected diabetes devices, providing a framework for risk-based, multi-stakeholder security requirements in the form of Protection Profiles and Security Targets. The standard is delivered through DTSec-approved testing laboratories (Booz Allen Hamilton, Brightsight, TUV Rheinland, UL), and certified devices include the Insulet Omnipod DASH System.
• DTMoSt Cybersecurity Standard Second consensus medical device cybersecurity standard developed by DTS, providing cybersecurity performance and assurance requirements for connected diabetes devices, building on the DTSec framework.
• Blood Glucose Monitor System (BGMS) Surveillance Program Independent post-market surveillance program that assesses the accuracy of cleared blood glucose monitoring systems against accepted standards, providing a DTS Seal of Approval to products meeting rigorous performance criteria. The program has tested 18 blood glucose monitoring systems across more than 1,000 subjects.
• Surveillance Error Grid Software Software tool for assessing clinical accuracy of blood glucose monitors using the Surveillance Error Grid analysis methodology. Distributed by DTS to support researchers, manufacturers, and regulators in evaluating device accuracy.
• Glycemia Risk Index (GRI) A metric developed by DTS that provides a single score for assessing glycemic control from continuous glucose monitoring data, complementing Time in Range measurements. Used to evaluate glycemic control in CGM users.
• iCoDE Standard Project Project developing EHR integration standards and recommendations for insulin delivery data, enabling better interoperability between diabetes devices and electronic health records. The 2025 iCoDE Report is the most recent published deliverable.
• Diabetes Technology Report Podcast Official podcast from Diabetes Technology Society featuring discussions on diabetes and health news and technology developments. Distributed to clinicians, researchers, and the broader diabetes technology community.
• Startup Showcase at DTM Program at the Diabetes Technology Meeting providing small companies with products in development the opportunity to present and exhibit to the diabetes technology community, including one complimentary registration to the three-day program and workshops plus space at a poster session.
• Salud Diabetes Dual-language website focused on diabetes and health news for the Spanish-speaking community, launched by DTS to extend diabetes technology information and education to Hispanic/Latino audiences.

Quantifiable outcome

• Only 6 of 18 blood glucose monitoring systems tested passed all 3 studies to receive the DTS Seal of Approval, demonstrating rigorous independent testing.
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

16 partnerships are on record, tiered core and minor.

• Kitalys InstitutecoreStrategic or Co-development Partner · 8 August 2024DTS, led by Dr. David Klonoff, and Kitalys Institute, led by Dr. Alexander Fleming, partnered to host a virtual webinar on 'Advanced Glycation Endproducts (AGEs)' in August 2024. AGEs are implicated in aging and complications of diabetes and other chronic diseases. The partnership brings together leading experts to examine the structure, pathological implications, and predictive value of AGEs.
• Sansum Diabetes Research InstitutecoreStrategic or Co-development PartnerCo-presenter of the Digital Diabetes Congress (DDC) with Sansum Diabetes Research Institute. Dr. David Kerr from Sansum serves as Director of Research and Innovation for DDC. The partnership combines DTS's expertise in diabetes technology with Sansum's research capabilities to advance digital health in diabetes care.
• American Association of Diabetes Educators (AADE)coreStrategic or Co-development PartnerAADE serves as a cooperating organization for the Clinical Diabetes Technology Meeting (CDTM), providing educational accreditation support and professional engagement for diabetes educators attending the conference.
• William Sansum Diabetes CenterminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM), contributing to the educational programming and accreditation of the conference.
• UCSF Diabetes CenterminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• Stanford University Department of PediatricsminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• Yale University Department of PediatricsminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• Barbara Davis Center for Childhood Diabetes, University of ColoradominorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• Joslin Diabetes CenterminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• University of Pittsburgh Diabetes InstituteminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• Mills-Peninsula Medical CenterminorStrategic or Co-development PartnerCooperating organization for Clinical Diabetes Technology Meeting (CDTM).
• BrightsightcoreImplementation/ SI/ Consulting PartnerDTSec-approved testing laboratory - the world's largest independent security evaluator for high-criticality electronic products such as financial transaction and industrial control systems. Brightsight provides independent security assessments of connected diabetes devices under the DTSec standard.
• Booz Allen Hamilton - Cyber Assurance Testing Lab (CATL)coreImplementation/ SI/ Consulting PartnerDTSec-approved testing laboratory providing management and technology consulting and engineering services. Booz Allen Hamilton evaluates connected diabetes devices for DTSec cybersecurity certification.
• TUV Rheinland North AmericacoreImplementation/ SI/ Consulting PartnerDTSec-approved testing laboratory that evaluated Insulet Corporation's Omnipod DASH System, the first insulin pump certified under the DTSec standard.
• Underwriters Laboratories (UL)coreImplementation/ SI/ Consulting PartnerDTSec-approved testing laboratory providing safety and security certification services for connected diabetes devices.
• KinexumcoreStrategic or Co-development PartnerRegulatory consulting firm led by Dr. Alexander Fleming, who serves as Founder and Executive Chairman. Kinexum contributes expertise in regulatory strategy for diabetes technology and is involved in the Kitalys Institute partnership with DTS for the AGEs webinar series.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• International Diabetes Federation: Global umbrella organization for national diabetes associations, convening the World Diabetes Congress and publishing Diabetes Research and Clinical Practice — directly comparable as the international peer society operating at global scope.
• Association for the Advancement of Medical Instrumentation (AAMI): Standards-developing organization for medical devices, including cybersecurity (e.g., AAMI TIR57, AAMI SW96) — the closest functional peer given DTS's role publishing DTSec/DTMoSt cybersecurity standards for medical devices.
• Endocrine Society: Professional society for endocrinologists running ENDO and publishing Journal of the Endocrine Society and Endocrinology — directly comparable as the peer clinical-specialty society whose audience overlaps with DTS clinicians and researchers.
• American Diabetes Association: Largest US diabetes non-profit, running professional conferences, publishing Diabetes Care, and setting clinical standards — directly comparable as a peer diabetes-focused scientific society with overlapping conference and journal models.
• JDRF (formerly Juvenile Diabetes Research Foundation): Major non-profit funding Type 1 diabetes research and advocacy with a strong technology/device focus — directly comparable as a peer diabetes-mission non-profit targeting device innovation and research translation.

Regional players

• EASD (European Association for the Study of Diabetes): European diabetes research society running the EASD Annual Meeting and Diabetologia journal — a strong regional peer with overlapping conference and publishing programs serving a primarily European audience.

Emerging players

• HITRUST Alliance: Healthcare-specific cybersecurity and information risk framework provider (HITRUST CSF) with a certification program — partially comparable as a healthcare cybersecurity standards/certification body that overlaps with DTSec's role for medical devices.
• MedISAO: Medical device cybersecurity information-sharing and analysis organization serving as a community for device manufacturers, hospitals, and researchers — comparable as a peer medical-device cybersecurity collective focused on standards and threat information.

Broad incumbents

• Underwriters Laboratories (UL): Global safety science organization providing cybersecurity testing and certification services, including acting as a DTSec-approved testing lab — comparable as a broad incumbent that competes for the same diabetes-device cybersecurity certification work.

Others

• Sansum Diabetes Research Institute: Santa Barbara diabetes research institute and DTS co-presenter of the Digital Diabetes Congress — comparable as an adjacent peer/partner in diabetes technology research and education programming.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/diabetestechsoc
• Facebookfacebook.com/diabetestechnologysociety
• LinkedInlinkedin.com/company/journal-of-diabetes-science-and-technology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diabetes Technology Society